SCHEMBL1817245

SCHEMBL1817245

Brc1ccc(-c2cccc3c2ccc2cc4ccccc4cc23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
HSD17B10 Q99714 3/20 0.44
CYP1B1 Q16678 2/20 0.44
HIF1A Q16665 2/20 0.44
CYP2A6 P11509 1/20 0.42
CYP1A2 P05177 3/20 0.41
ERBB2 P04626 1/20 0.41
FYN P06241 1/20 0.41
MAOA P21397 1/20 0.41
ACHE P22303 1/20 0.41
AHR P35869 1/20 0.41
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
CYP1A1 P04798 1/20 0.39
HPGD P15428 2/20 0.39
GRM2 Q14416 1/20 0.38
HPRT1 P00492 1/20 0.38
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2995209 0.91 ALDH1A1 (0.52) ALDH1A1HSD17B10CYP1B1HIF1ACYP1A2
SCHEMBL27831504 0.90 CYP2A6 (0.43) ALDH1A1HSD17B10HIF1ACYP2A6CYP1A2
SCHEMBL27717449 0.88 CYP2A6 (0.42) ALDH1A1HSD17B10HIF1ACYP2A6CYP1A2
SCHEMBL31290733 0.88 ALDH1A1 (0.52) ALDH1A1HSD17B10CYP1B1HIF1ACYP1A2
SCHEMBL2859818 0.86 ALDH1A1 (0.50) ALDH1A1HSD17B10CYP1B1HIF1ACYP1A2
SCHEMBL1527430 0.86 HPRT1 (0.54) ALDH1A1HSD17B10CYP1B1HIF1ACYP2A6
SCHEMBL1815030 0.85 ALDH1A1 (0.42) ALDH1A1HSD17B10CYP1B1HIF1ACYP2A6
SCHEMBL2867368 0.84 ALDH1A1 (0.52) ALDH1A1HSD17B10CYP1B1HIF1ACYP2A6
SCHEMBL1689466 0.83 ESR1 (0.44) ALDH1A1HDAC8HDAC6HPGDGRM2
SCHEMBL1816243 0.82 ESR1 (0.46) ALDH1A1HSD17B10CYP1B1HIF1ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120217449-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2012-08-30 US disclosed
US-20120217449-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2012-08-30 US disclosed
US-20120217449-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2012-08-30 US disclosed
WO-2011054442-A2 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2011-05-12 WO disclosed
WO-2011054442-A2 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2011-05-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120217449-A1 MATERIALS FOR ELECTRONIC DEVICES EFNA1, DDT, ERCC1 ALDH1A1 261/4885HSD17B10 3445/4885CYP1B1 417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.